Experimental and clinical evidences for glucose control in intensive care: Is infused glucose the key point for study interpretation?

Critical Care

Volumn 18, Issue 4, 2014, Pages

  Mazeraud, Aurélien ^a,b   Polito, Andrea ^a,c   Annane, Djillali ^c  

^a INSTITUT PASTEUR   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c LABORATOIRE DES SCIENCES DU CLIMAT ET DE L ENVIRONNEMENT   (France)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN; ANTIDIABETIC AGENT;

CARDIOVASCULAR SYSTEM; CENTRAL NERVOUS SYSTEM; CLINICAL TRIAL (TOPIC); CRITICALLY ILL PATIENT; ENDOTHELIUM; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; GLYCEMIC CONTROL; HEART; HUMAN; HYPERGLYCEMIA; HYPOGLYCEMIA; IMMUNE SYSTEM; IMMUNITY; INSULIN TREATMENT; INTENSIVE CARE; KIDNEY; LIVER; METABOLISM; PATHOGENESIS; PERIPHERAL NERVOUS SYSTEM; PRIORITY JOURNAL; REVIEW; STRESS; STRESS INDUCED HYPERGLYCEMIA; BLOOD; COMPLICATION; INTENSIVE CARE UNIT; PHYSIOLOGICAL STRESS; RISK FACTOR;

CRITICAL CARE; HUMANS; HYPERGLYCEMIA; HYPOGLYCEMIC AGENTS; INSULIN; INTENSIVE CARE UNITS; RISK FACTORS; STRESS, PHYSIOLOGICAL;

EID: 84904677878     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc13998     Document Type: Review

References (72)

1. McCowen KC, Malhotra A, Bistrian BR. Stress-induced hyperglycemia. Crit Care Clin 2001, 17:107-124. 10.1016/S0749-0704(05)70154-8, 11219223.
2. Salim A, Hadjizacharia P, Dubose J, Brown C, Inaba K, Chan LS, Margulies D. Persistent hyperglycemia in severe traumatic brain injury: an independent predictor of outcome. Am Surg 2009, 75:25-29.
3. Finney SJ, Zekveld C, Elia A, Evans TW. Glucose control and mortality in critically ill patients. JAMA 2003, 290:2041-2047. 10.1001/jama.290.15.2041, 14559958.
4. van den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M, Vlasselaers D, Ferdinande P, Lauwers P, Bouillon R. Intensive insulin therapy in the critically ill patients. N Engl J Med 2001, 345:1359-1367. 10.1056/NEJMoa011300, 11794168.
5. Finfer S, Chittock DR, Su SY, Blair D, Foster D, Dhingra V, Bellomo R, Cook D, Dodek P, Henderson WR, Hébert PC, Heritier S, Heyland DK, McArthur C, McDonald E, Mitchell I, Myburgh JA, Norton R, Potter J, Robinson BG, Ronco JJ, . NICE-SUGAR Study Investigators Intensive versus conventional glucose control in critically ill patients. N Engl J Med 2009, 360:1283-1297. NICE-SUGAR Study Investigators.
6. Marik PE, Preiser JC. Toward understanding tight glycemic control in the ICU: a systematic review and metaanalysis. Chest 2010, 137:544-551. 10.1378/chest.09-1737, 20018803.
7. Annane D, Cariou A, Maxime V, Azoulay E, D'honneur G, Timsit JF, Cohen Y, Wolf M, Fartoukh M, Adrie C, Santré C, Bollaert PE, Mathonet A, Amathieu R, Tabah A, Clec'h C, Mayaux J, Lejeune J, Chevret S, . COIITSS Study Investigators Corticosteroid treatment and intensive insulin therapy for septic shock in adults: a randomized controlled trial. JAMA 2010, 303:341-348. COIITSS Study Investigators.
8. Arabi YM, Dabbagh OC, Tamim HM, Al-Shimemeri AA, Memish ZA, Haddad SH, Syed SJ, Giridhar HR, Rishu AH, Al-Daker MO, Kahoul SH, Britts RJ, Sakkijha MH. Intensive versus conventional insulin therapy: a randomized controlled trial in medical and surgical critically ill patients. Crit Care Med 2008, 36:3190-3197. 10.1097/CCM.0b013e31818f21aa, 18936702.
9. De La Rosa GC, Donado JH, Restrepo AH, Quintero AM, González LG, Saldarriaga NE, Bedoya M, Toro JM, Velásquez JB, Valencia JC, Arango CM, Aleman PH, Vasquez EM, Chavarriaga JC, Yepes A, Pulido W, Cadavid CA, . Grupo de Investigacion en Cuidado intensivo: GICI-HPTU Strict glycaemic control in patients hospitalised in a mixed medical and surgical intensive care unit: a randomised clinical trial. Crit Care 2008, 12:R120. 10.1186/cc7017, 2592751, 18799004, Grupo de Investigacion en Cuidado intensivo: GICI-HPTU.
10. Preiser JC, Devos P, Ruiz-Santana S, Mélot C, Annane D, Groeneveld J, Iapichino G, Leverve X, Nitenberg G, Singer P, Wernerman J, Joannidis M, Stecher A, Chioléro R. A prospective randomised multi-centre controlled trial on tight glucose control by intensive insulin therapy in adult intensive care units: the Glucontrol study. Intensive Care Med 2009, 35:1738-1748. 10.1007/s00134-009-1585-2, 19636533.
11. Van den Berghe G, Wilmer A, Hermans G, Meersseman W, Wouters PJ, Milants I, Van Wijngaerden E, Bobbaers H, Bouillon R. Intensive insulin therapy in the medical ICU. N Engl J Med 2006, 354:449-461. 10.1056/NEJMoa052521, 16452557.
12. Baird TA, Parsons MW, Phanh T, Butcher KS, Desmond PM, Tress BM, Colman PG, Chambers BR, Davis SM. Persistent poststroke hyperglycemia is independently associated with infarct expansion and worse clinical outcome. Stroke 2003, 34:2208-2214. 10.1161/01.STR.0000085087.41330.FF, 12893952.
13. Capes SE, Hunt D, Malmberg K, Gerstein HC. Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview. Lancet 2000, 355:773-778. 10.1016/S0140-6736(99)08415-9, 10711923.
14. McGuinness OP, Snowden RT, Moran C, Neal DW, Fujiwara T, Cherrington AD. Impact of acute epinephrine removal on hepatic glucose metabolism during stress hormone infusion. Metabolism 1999, 48:910-914. 10.1016/S0026-0495(99)90228-7, 10421235.
15. Li L, Messina JL. Acute insulin resistance following injury. Trends Endocrinol Metab 2009, 20:429-435. 10.1016/j.tem.2009.06.004, 2939005, 19800814.
16. Qi C, Pekala PH. Tumor necrosis factor-alpha-induced insulin resistance in adipocytes. Proc Soc Exp Biol Med 2000, 223:128-135. 10.1046/j.1525-1373.2000.22318.x, 10654615.
17. Stephens JM, Bagby GJ, Pekala PH, Shepherd RE, Spitzer JJ, Lang CH. Differential regulation of glucose transporter gene expression in adipose tissue or septic rats. Biochem Biophys Res Commun 1992, 183:417-422. 10.1016/0006-291X(92)90497-9, 1550551.
18. Marik PE, Bellomo R. Stress hyperglycemia: an essential survival response!. Crit Care 2013, 17:305. 10.1186/cc12514, 3672537, 23470218.
19. Thompson LH, Kim HT, Ma Y, Kokorina NA, Messina JL. Acute, muscle-type specific insulin resistance following injury. Mol Med 2008, 14:715-723. 2582859, 19009015.
20. Meszaros K, Lang CH, Bagby GJ, Spitzer JJ. Contribution of different organs to increased glucose consumption after endotoxin administration. J Biol Chem 1987, 262:10965-10970.
21. Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature 2001, 414:813-820. 10.1038/414813a, 11742414.
22. Nishikawa T, Edelstein D, Du XL, Yamagishi S, Matsumura T, Kaneda Y, Yorek MA, Beebe D, Oates PJ, Hammes HP, Giardino I, Brownlee M. Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature 2000, 404:787-790. 10.1038/35008121, 10783895.
23. Polito A, Brouland JP, Porcher R, Sonneville R, Siami S, Stevens RD, Guidoux C, Maxime V, de la Grandmaison GL, Chrétien FC, Gray F, Annane D, Sharshar T. Hyperglycaemia and apoptosis of microglial cells in human septic shock. Crit Care 2011, 15:R131. 10.1186/cc10244, 3218997, 21612615.
24. Thorens B, Mueckler M. Glucose transporters in the 21st Century. Am J Physiol Endocrinol Metab 2010, 298:E141-E145. 10.1152/ajpendo.00712.2009, 2822486, 20009031.
25. Zhang WW, Zhang L, Hou WK, Xu YX, Xu H, Lou FC, Zhang Y, Wang Q. Dynamic expression of glucose transporters 1 and 3 in the brain of diabetic rats with cerebral ischemia reperfusion. Chin Med J (Engl) 2009, 122:1996-2001.
26. Kamada H, Yu F, Nito C, Chan PH. Influence of hyperglycemia on oxidative stress and matrix metalloproteinase-9 activation after focal cerebral ischemia/reperfusion in rats: relation to blood-brain barrier dysfunction. Stroke 2007, 38:1044-1049. 10.1161/01.STR.0000258041.75739.cb, 1828129, 17272778.
27. Bilotta F, Spinelli A, Giovannini F, Doronzio A, Delfini R, Rosa G. The effect of intensive insulin therapy on infection rate, vasospasm, neurologic outcome, and mortality in neurointensive care unit after intracranial aneurysm clipping in patients with acute subarachnoid hemorrhage: a randomized prospective pilot trial. J Neurosurg Anesthesiol 2007, 19:156-160. 10.1097/ANA.0b013e3180338e69, 17592345.
28. Bilotta F, Caramia R, Cernak I, Paoloni FP, Doronzio A, Cuzzone V, Santoro A, Rosa G. Intensive insulin therapy after severe traumatic brain injury: a randomized clinical trial. Neurocrit Care 2008, 9:159-166. 10.1007/s12028-008-9084-9, 18373223.
29. Azevedo JR, Lima ER, Cossetti RJ, Azevedo RP. Intensive insulin therapy versus conventional glycemic control in patients with acute neurological injury: a prospective controlled trial. Arq Neuropsiquiatr 2007, 65:733-738. 10.1590/S0004-282X2007000500001, 17952272.
30. Russell ST, Rajani S, Dhadda RS, Tisdale MJ. Mechanism of induction of muscle protein loss by hyperglycaemia. Exp Cell Res 2009, 315:16-25. 10.1016/j.yexcr.2008.10.002, 18973755.
31. Spolarics Z, Pekala PH, Bagby GJ, Spitzer JJ. Brief endotoxemia markedly increases expression of GLUT1 glucose transporter in Kupffer, hepatic endothelial and parenchymal cells. Biochem Biophys Res Commun 1993, 193:1211-1215. 10.1006/bbrc.1993.1754, 8323543.
32. Battelino T, Goto M, Krzisnik C, Zeller WP. Tissue glucose transport and glucose transporters in suckling rats with endotoxic shock. Shock 1996, 6:259-262.
33. Vanhorebeek I, De Vos R, Mesotten D, Wouters PJ, De Wolf-Peeters C, Van den Berghe G. Protection of hepatocyte mitochondrial ultrastructure and function by strict blood glucose control with insulin in critically ill patients. Lancet 2005, 365:53-59. 10.1016/S0140-6736(04)17665-4, 15639679.
34. Andreasen AS, Pedersen-Skovsgaard T, Berg RM, Svendsen KD, Feldt-Rasmussen B, Pedersen BK, Moller K. Type 2 diabetes mellitus is associated with impaired cytokine response and adhesion molecule expression in human endotoxemia. Intensive Care Med 2010, 36:1548-1555. 10.1007/s00134-010-1845-1, 20229041.
35. Quagliaro L, Piconi L, Assaloni R, Da Ros R, Maier A, Zuodar G, Ceriello A. Intermittent high glucose enhances ICAM-1, VCAM-1 and E-selectin expression in human umbilical vein endothelial cells in culture: the distinct role of protein kinase C and mitochondrial superoxide production. Atherosclerosis 2005, 183:259-267. 10.1016/j.atherosclerosis.2005.03.015, 16285992.
36. Mochizuki K, Shimada M, Tanaka Y, Fukaya N, Goda T. Reduced expression of beta2 integrin genes in rat peripheral leukocytes by inhibiting postprandial hyperglycemia. Biosci Biotechnol Biochem 2010, 74:2470-2474. 10.1271/bbb.100554, 21150098.
37. Turina M, Fry DE, Polk HC. Acute hyperglycemia and the innate immune system: clinical, cellular, and molecular aspects. Crit Care Med 2005, 33:1624-1633. 10.1097/01.CCM.0000170106.61978.D8, 16003073.
38. McManus LM, Bloodworth RC, Prihoda TJ, Blodgett JL, Pinckard RN. Agonist-dependent failure of neutrophil function in diabetes correlates with extent of hyperglycemia. J Leukoc Biol 2001, 70:395-404.
39. Stegenga ME, van der Crabben SN, Dessing MC, Pater JM, van den Pangaart PS, de Vos AF, Tanck MW, Roos D, Sauerwein HP, van der Poll T. Effect of acute hyperglycaemia and/or hyperinsulinaemia on proinflammatory gene expression, cytokine production and neutrophil function in humans. Diabet Med 2008, 25:157-164. 10.1111/j.1464-5491.2007.02348.x, 2268957, 18290856.
40. Schmidt C, Hocherl K, Bucher M. Regulation of renal glucose transporters during severe inflammation. Am J Physiol Renal Physiol 2007, 292:F804-F811.
41. Van den Berghe G, Wouters PJ, Bouillon R, Weekers F, Verwaest C, Schetz M, Vlasselaers D, Ferdinande P, Lauwers P. Outcome benefit of intensive insulin therapy in the critically ill: insulin dose versus glycemic control. Crit Care Med 2003, 31:359-366. 10.1097/01.CCM.0000045568.12881.10, 12576937.
42. Ortiz A, Ziyadeh FN, Neilson EG. Expression of apoptosis-regulatory genes in renal proximal tubular epithelial cells exposed to high ambient glucose and in diabetic kidneys. J Investig Med 1997, 45:50-56.
43. Schetz M, Vanhorebeek I, Wouters PJ, Wilmer A, Van den Berghe G. Tight blood glucose control is renoprotective in critically ill patients. J Am Soc Nephrol 2008, 19:571-578. 10.1681/ASN.2006101091, 2391044, 18235100.
44. Beadle RM, Frenneaux M. Modification of myocardial substrate utilisation: a new therapeutic paradigm in cardiovascular disease. Heart 2010, 96:824-830. 10.1136/hrt.2009.190256, 20478861.
45. Langouche L, Vanhorebeek I, Vlasselaers D, Vander Perre S, Wouters PJ, Skogstrand K, Hansen TK, Van den Berghe G. Intensive insulin therapy protects the endothelium of critically ill patients. J Clin Invest 2005, 115:2277-2286. 10.1172/JCI25385, 1180545, 16075063.
46. Jessani SS, Lane DA, Shantsila E, Watson T, Millane TA, Lip GY. Impaired glucose tolerance and endothelial damage, as assessed by levels of von Willebrand factor and circulating endothelial cells, following acute myocardial infarction. Ann Med 2009, 41:608-618. 10.1080/07853890903159256, 20021313.
47. LaDisa JF, Krolikowski JG, Pagel PS, Warltier DC, Kersten JR. Cardioprotection by glucose-insulin-potassium: dependence on KATP channel opening and blood glucose concentration before ischemia. Am J Physiol Heart Circ Physiol 2004, 287:H601-H607. 10.1152/ajpheart.00122.2004, 15044191.
48. Dhainaut JF, Huyghebaert MF, Monsallier JF, Lefevre G, Dall'Ava-Santucci J, Brunet F, Villemant D, Carli A, Raichvarg D. Coronary hemodynamics and myocardial metabolism of lactate, free fatty acids, glucose, and ketones in patients with septic shock. Circulation 1987, 75:533-541. 10.1161/01.CIR.75.3.533, 3815765.
49. Krinsley JS. Association between hyperglycemia and increased hospital mortality in a heterogeneous population of critically ill patients. Mayo Clin Proc 2003, 78:1471-1478. 10.4065/78.12.1471, 14661676.
50. Brunkhorst FM, Engel C, Bloos F, Meier-Hellmann A, Ragaller M, Weiler N, Moerer O, Gruendling M, Oppert M, Grond S, Olthoff D, Jaschinski U, John S, Rossaint R, Welte T, Schaefer M, Kern P, Kuhnt E, Kiehntopf M, Hartog C, Natanson C, Loeffler M, Reinhart K, . German Competence Network Sepsis (SepNet) Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med 2008, 358:125-139. 10.1056/NEJMoa070716, 18184958, German Competence Network Sepsis (SepNet).
51. Chase JG, Pretty CG, Pfeifer L, Shaw GM, Preiser JC, Le Compte AJ, Lin J, Hewett D, Moorhead KT, Desaive T. Organ failure and tight glycemic control in the SPRINT study. Crit Care 2010, 14:R154. 10.1186/cc9224, 2945138, 20704712.
52. der Voort PH, Feenstra RA, Bakker AJ, Heide L, Boerma EC, van der Horst IC. Intravenous glucose intake independently related to intensive care unit and hospital mortality: an argument for glucose toxicity in critically ill patients. Clin Endocrinol (Oxf) 2006, 64:141-145.
53. Arabi YM, Tamim HM, Dhar GS, Al-Dawood A, Al-Sultan M, Sakkijha MH, Kahoul SH, Brits R. Permissive underfeeding and intensive insulin therapy in critically ill patients: a randomized controlled trial. Am J Clin Nutr 2011, 93:569-577. 10.3945/ajcn.110.005074, 21270385.
54. Casaer MP, Mesotten D, Hermans G, Wouters PJ, Schetz M, Meyfroidt G, Van Cromphaut S, Ingels C, Meersseman P, Muller J, Vlasselaers D, Debaveye Y, Desmet L, Dubois J, Van Assche A, Vanderheyden S, Wilmer A, Van den Berghe G. Early versus late parenteral nutrition in critically ill adults. N Engl J Med 2011, 365:506-517. 10.1056/NEJMoa1102662, 21714640.
55. Vriesendorp TM, DeVries JH, van Santen S, Moeniralam HS, de Jonge E, Roos YB, Schultz MJ, Rosendaal FR, Hoekstra JB. Evaluation of short-term consequences of hypoglycemia in an intensive care unit. Crit Care Med 2006, 34:2714-2718. 10.1097/01.CCM.0000241155.36689.91, 16943734.
56. Mesotten D, Gielen M, Sterken C, Claessens K, Hermans G, Vlasselaers D, Lemiere J, Lagae L, Gewillig M, Eyskens B, Vanhorebeek I, Wouters PJ, Van den Berghe G. Neurocognitive development of children 4 years after critical illness and treatment with tight glucose control: a randomized controlled trial. JAMA 2012, 308:1641-1650. 10.1001/jama.2012.12424, 23101118.
57. Duning T, van den Heuvel I, Dickmann A, Volkert T, Wempe C, Reinholz J, Lohmann H, Freise H, Ellger B. Hypoglycemia aggravates critical illness-induced neurocognitive dysfunction. Diabetes Care 2010, 33:639-644. 10.2337/dc09-1740, 2827523, 20032274.
58. Bagshaw SM, Bellomo R, Jacka MJ, Egi M, Hart GK, George C. The impact of early hypoglycemia and blood glucose variability on outcome in critical illness. Crit Care 2009, 13:R91. 10.1186/cc7921, 2717463, 19534781.
59. Kosiborod M, Inzucchi SE, Goyal A, Krumholz HM, Masoudi FA, Xiao L, Spertus JA. Relationship between spontaneous and iatrogenic hypoglycemia and mortality in patients hospitalized with acute myocardial infarction. JAMA 2009, 301:1556-1564. 10.1001/jama.2009.496, 19366775.
60. Arabi YM, Tamim HM, Rishu AH. Hypoglycemia with intensive insulin therapy in critically ill patients: predisposing factors and association with mortality. Crit Care Med 2009, 37:2536-2544. 10.1097/CCM.0b013e3181a381ad, 19623047.
61. Krinsley JS, Grover A. Severe hypoglycemia in critically ill patients: risk factors and outcomes. Crit Care Med 2007, 35:2262-2267. 10.1097/01.CCM.0000282073.98414.4B, 17717490.
62. Carré JE, Orban JC, Re L, Felsmann K, Iffert W, Bauer M, Suliman HB, Piantadosi CA, Mayhew TM, Breen P, Stotz M, Singer M. Survival in critical illness is associated with early activation of mitochondrial biogenesis. Am J Respir Crit Care Med 2010, 182:745-751. 10.1164/rccm.201003-0326OC, 2949402, 20538956.
63. Sharshar T, Bastuji-Garin S, Stevens RD, Durand MC, Malissin I, Rodriguez P, Cerf C, Outin H, De Jonghe B. Presence and severity of intensive care unit-acquired paresis at time of awakening are associated with increased intensive care unit and hospital mortality. Crit Care Med 2009, 37:3047-3053. 10.1097/CCM.0b013e3181b027e9, 19770751.
64. Langouche L, Vander Perre S, Wouters PJ, D'Hoore A, Hansen TK, Van den Berghe G. Effect of intensive insulin therapy on insulin sensitivity in the critically ill. J Clin Endocrinol Metab 2007, 92:3890-3897. 10.1210/jc.2007-0813, 17666481.
65. Jeschke MG, Rensing H, Klein D, Schubert T, Mautes AE, Bolder U, Croner RS. Insulin prevents liver damage and preserves liver function in lipopolysaccharide-induced endotoxemic rats. J Hepatol 2005, 42:870-879. 10.1016/j.jhep.2004.12.036, 15885358.
66. Mesotten D, Delhanty PJ, Vanderhoydonc F, Hardman KV, Weekers F, Baxter RC, Van Den Berghe G. Regulation of insulin-like growth factor binding protein-1 during protracted critical illness. J Clin Endocrinol Metab 2002, 87:5516-5523. 10.1210/jc.2002-020664, 12466347.
67. Ellger B, Debaveye Y, Vanhorebeek I, Langouche L, Giulietti A, Van Etten E, Herijgers P, Mathieu C, Van den Berghe G. Survival benefits of intensive insulin therapy in critical illness: impact of maintaining normoglycemia versus glycemia-independent actions of insulin. Diabetes 2006, 55:1096-1105. 10.2337/diabetes.55.04.06.db05-1434, 16567534.
68. Vanhorebeek I, Ellger B, De Vos R, Boussemaere M, Debaveye Y, Perre SV, Rabbani N, Thornalley PJ, Van den Berghe G. Tissue-specific glucose toxicity induces mitochondrial damage in a burn injury model of critical illness. Crit Care Med 2009, 37:1355-1364. 10.1097/CCM.0b013e31819cec17, 19242345.
69. Deng HP, Chai JK. The effects and mechanisms of insulin on systemic inflammatory response and immune cells in severe trauma, burn injury, and sepsis. Int Immunopharmacol 2009, 9:1251-1259. 10.1016/j.intimp.2009.07.009, 19647101.
70. Lang CH, Dobrescu C, Meszaros K. Insulin-mediated glucose uptake by individual tissues during sepsis. Metabolism 1990, 39:1096-1107. 10.1016/0026-0495(90)90172-9, 2215256.
71. Holger JS, Dries DJ, Barringer KW, Peake BJ, Flottemesch TJ, Marini JJ. Cardiovascular and metabolic effects of high-dose insulin in a porcine septic shock model. Acad Emerg Med 2010, 17:429-435. 10.1111/j.1553-2712.2010.00695.x, 20370783.
72. Malmberg K, Norhammar A, Ryden L. Insulin treatment post myocardial infarction: the DIGAMI study. Adv Exp Med Biol 2001, 498:279-284. 10.1007/978-1-4615-1321-6_35, 11900380.